AnalysisNews

CANF today

$1.51-$0.02 (-1.31%)close Nov 18, 2026

Trend

DailyDowntrend (confirmed)

4 hourExpanding

1 hourExpanding

15 minSymmetric Triangle

5 minSymmetric Triangle

Daily trend turns up above $1.70

Key levels

Resistance$2.14

Resistance$1.70

Support$1.50

Latest news & SEC filings

No headlines in the last 90 days.

About Can-Fite BioPharma

Can-Fite BioPharma is a drug developer working on orally taken small molecules that act on the A3 adenosine receptor. Its three main candidates are Piclidenoson, Namodenoson, and CF602, which are being tested for oncology, hepatic, and inflammatory conditions. The company is based in Israel and has no products on the market yet.

Based on the company's 20-F filed Mar 26, 2026.

NYSE · Healthcare

Can-Fite BioPharma Ltd. (CANF)

$1.51-0.02 (-1.31%)
WATCHLISTGrade: C+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
1.541.651.771.881.51Oct 16Oct 26Nov 3Nov 11
High1.61
Low1.47
Open1.55
Volume12K
Avg Vol26K
VWAP1.51
30d High2.00
30d Low1.42
30d Chg-24.50%

What Is the Price Target for CANF?

SEPT Low Target

$5.00

SEPT Mid Target

$7.00

SEPT High Target

$8.00

Analyst Consensus

$7.00

Current: $1.53Upside: +357.5%Confidence: 65%Method: Analyst Consensus

Is CANF a Buy or Sell Right Now?

51
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing -39.9% YoY with DECLINING trend — consistent growth.

Test your own strategy on CANF

Describe your strategy in plain words, then scan, alert, backtest and paper trade it on CANF with SEPT’s own market data.

Start Free Trial →

Is CANF Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B, Analyst Consensus

Fair Value

$7.46

0

Moat Score

NONE

1/9

Piotroski Score

N/A

Altman Z-Score

What Is Smart Money Doing with CANF?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See Smart Money Data →

CANF Growth Story

Revenue YoY

-39.9%

3yr Revenue CAGR

-20.6%

EPS Growth YoY

45.03%

FCF Growth YoY

-17.1%

Revenue Trend

DECLINING

Dark Pool Trades for CANF

PREVIEW

Recent off-exchange (dark pool) prints for CANF: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

TimePriceSizeValueSide
16:06:25$1.501,000$$2KMIDPOINT
14:44:22$1.502,000$$3KSELL
14:21:53$1.542,635$$4KSELL
14:11:06$1.541,600$$2KSELL
14:11:06$1.541,421$$2KSELL

5 dark pool trades shown · $$13K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Can-Fite BioPharma Ltd. (CANF) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

Your strategy, tested before real money.

Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

Try SEPT Free for 7 Days →

CANF — frequently asked questions

What is CANF stock price today?

Can-Fite BioPharma Ltd. (CANF) is at $1.51, down 1.31% (-$0.02) at the Nov 18, 2026 close.

What is the CANF price target?

The average analyst price target for CANF is $7.00, ranging from $5 to $8, based on 3 analysts.

What do analysts rate CANF?

Analyst ratings for CANF: 1 Buy, 2 Hold, 0 Sell — consensus Hold.

Did CANF beat earnings?

CANF last reported on Sep 8, 2026: EPS -$1.24 vs -$0.33 expected — a miss of 275.8%.

What are CANF support and resistance levels?

Support: $1.50. Resistance: $1.70, $2.14, $2.27.

What are insiders doing with CANF?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.